Mirova Neogenomics Inc Transaction History

Mirova

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$9.09 - $19.45 $371,562 - $795,038	-40,876 Reduced 52.67%	36,731 $639,000
Q2 2022 Aug 12, 2022	BUY	$7.06 - $13.97 $18,765 - $37,132	2,658 Added 3.55%	77,607 $632,000
Q1 2022 May 13, 2022	BUY	$12.15 - $35.28 $130,029 - $377,566	10,702 Added 16.66%	74,949 $910,000
Q4 2021 Feb 14, 2022	BUY	$30.49 - $48.49 $493,755 - $785,247	16,194 Added 33.7%	64,247 $2.19 Million
Q1 2021 May 14, 2021	BUY	$41.56 - $59.88 $936,970 - $1.35 Million	22,545 Added 88.38%	48,053 $2.32 Million
Q4 2020 Feb 12, 2021	BUY	$36.08 - $56.47 $920,328 - $1.44 Million	25,508 New	25,508 $1.37 Million

295

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.16B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Mirova, based on Form 13F filings with the SEC.

Stay updated on Mirova with notifications on news.